撰文丨王聪编辑丨王多鱼排版丨水成文病理激活的免疫抑制性中性粒细胞会削弱癌症免疫疗法的疗效。趋化因子受体 CXCR4 是造血和中性粒细胞生物学的核心调控因子，是一个颇具吸引力的癌症治疗靶点。2025 年 6 月 26 日，哥伦比亚大学 Timothy ...

On May 18, Americans learned that former President Joe Biden has stage 4 cancer that has, unfortunately, metastasized to his bones. It's sad that Biden, who for decades served our nation as a ...

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like allergy drugs to fight it.

On June 9, Jupiter, our gas giant planet of luck, abundance, games of chance, and inclinations of excess, will set up his roulette wheel in the breast milk founts of Cancer for the first time in ov… ...

Observational studies linking bowel cancer to a variety of non-hereditary factors including obesity, alcohol intake and low physical activity have not uncovered anything unique to early-onset cases.

Joe Biden was not screened for prostate cancer during his four years as president, in line with medical recommendations for men 70 or older. Hotspots ranked Start the day smarter ☀️ Funniest ...

For most men a prostate tumour will grow either slowly or not at all, meaning they will die with the cancer but not of it. (For that reason many doctors think men over 70 should not generally get ...

Currently, screening for anal cancer is recommended for high risk groups — such as people with HIV, those who’ve had bone marrow transplants and other immunocompromised individuals — but ...

Understanding Biden's prostate cancer diagnosis 02:44. Former President Joe Biden has been diagnosed with metastatic prostate cancer at age 82. The former president's office said he has an ...

Doctor explains how Biden's prostate cancer could have advanced undetected 02:20. Former President Joe Biden received his last known blood test to check for prostate cancer in 2014, a spokesperson ...

A new means of prostate cancer screening could emerge as an alternative for the PSA test, which has long been the first-line option. Researchers and doctors discuss the findings.

The US Preventive Services Task Force recommends screening for cervical cancer with cervical cytology – also known as a Pap test or Pap smear – every three years for women ages 21 to 29. For ...